¿Disminuye la eficacia o la seguridad de las vacunas frente a la COVID-19 en los pacientes con dolor crónico?
PDF
HTML

Referencias

1. Miller DC, Patel J, Gill J, Mattie R, Saffarian M, Byron DO, et al. Corticosteroid Injections and COVID-19 Infection Risk. Pain Med. 2020;21(8):1703-6. DOI: 10.1093/pm/pnaa199.

2. Chakravarthy K, Strand N, Frosch A, Sayed D, Narra LR, Chaturvedi R, et al. Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2021;14:623-9. DOI: 10.2147/JPR.S302115.

3. Lee H, Punt JA, Patel J, Stojanovic MJ, Duszynski BS, McCormick ZL. The Spine Intervention Society’s Patient Safety Committee. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines? Pain Med. 2021;22(6):1441-64. DOI: 10.1093/pm/pnab130.

4. Sytsma TT, Greenlund LK, Greenlund LS. Joint corticosteroid injection associated with increased influenza risk. Mayo Clin Proc Innov Qual Outcomes 2018;2(2):194-8. DOI: 10.1016/j.mayocpiqo.2018.01.005.

Descargas

##plugins.themes.healthSciences.displayStats.noStats##